Strategic Blueprint LLC Sells 1,000 Shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY)
Strategic Blueprint LLC cut its stake in CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) by 6.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 15,800 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the period. Strategic Blueprint LLC’s holdings in CymaBay Therapeutics were worth $373,000 at the end of the most […]
More Stories
Maverix Metals (CVE:MMX) Trading 4.7% Higher – What’s Next?
Maverix Metals Inc (CVE:MMX – Get Free Report)’s share price was up 4.7% during trading on Thursday . The company...
Uniserve Communications (CVE:USS) Trading Up 14.3% – What’s Next?
Shares of Uniserve Communications Co. (CVE:USS – Get Free Report) rose 14.3% during mid-day trading on Thursday . The stock...
WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM) Stock Price Down 0.3% – Here’s What Happened
WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM – Get Free Report)’s share price fell 0.3% during trading on Thursday ....
Reserve Petroleum (OTCMKTS:RSRV) Stock Price Down 6.2% – What’s Next?
The Reserve Petroleum Company (OTCMKTS:RSRV – Get Free Report) traded down 6.2% during mid-day trading on Thursday . The company...
Keystone Law Group (LON:KEYS) Stock Price Down 1.8% – Here’s Why
Keystone Law Group plc (LON:KEYS – Get Free Report)’s share price dropped 1.8% during trading on Thursday . The stock...
GreenPower Motor (CVE:GPV) Stock Price Up 38.1% – Still a Buy?
GreenPower Motor Company Inc. (CVE:GPV – Get Free Report) traded up 38.1% during mid-day trading on Saturday . The stock...